Pages that link to "Q35006833"
Jump to navigation
Jump to search
The following pages link to Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience (Q35006833):
Displaying 6 items.
- Continuous Glucose Monitoring Systems: A Review (Q36335124) (← links)
- Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study (Q36968348) (← links)
- A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy (Q37154369) (← links)
- Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps (Q37972359) (← links)
- Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy. (Q43718003) (← links)
- Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis (Q90471109) (← links)